Results 81 to 90 of about 176,563 (257)
Spectral Properties of Dual Unit Gain Graphs
SymmetryIn this paper, we study dual quaternion, dual complex unit gain graphs, and their spectral properties in a unified frame of dual unit gain graphs. Unit dual quaternions represent rigid movements in the 3D space, and have wide applications in robotics and computer graphics. Dual complex numbers have found application in brain science recently.
Chunfeng Cui +3 more
openaire +2 more sources
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
Adaptive Graph Learning with Multimodal Fusion for Emotion Recognition in Conversation
BiomimeticsRobust emotion recognition is a prerequisite for natural, fluid human–computer interaction, yet conversational settings remain challenging because emotions are shaped simultaneously by global topic flow and local speaker-to-speaker dependencies. Here, we
Jian Liu +6 more
doaj +1 more source
A Mathematical Bibliography of Signed and Gain Graphs and Allied Areas [PDF]
The Electronic Journal of Combinatorics, 2018 A signed graph is a graph whose edges are labeled by signs. This is a bibliography of signed graphs and related mathematics.Several kinds of labelled graph have been called "signed" yet are mathematically very different. I distinguish four types:Group-signed graphs: the edge labels are elements of a 2-element group and are multiplied around a polygon ...
openaire +2 more sources
Molecular Oncology, EarlyView.In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
A switching method for constructing cospectral gain graphs
Discrete MathematicsA gain graph over a group $G$, also referred to as $G$-gain graph, is a graph where an element of a group $G$, called gain, is assigned to each oriented edge, in such a way that the inverse element is associated with the opposite orientation. Gain graphs can be regarded as a generalization of signed graphs, among others.
Aida Abiad +2 more
openaire +4 more sources
Molecular Oncology, EarlyView.We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
Molecular Oncology, EarlyView.In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3
Molecular Oncology, EarlyView.PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh +12 more
wiley +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source